THE ASTRAZENECA vaccine rollout has been dogged by problems in Europe, with many countries sitting on unused supplies over blood clot fears. Despite regulatory bodies concluding there is no causation, rare cases of blood clots do appear to be greater in a younger cohort. Now Professor Neil Ferguson has weighed in on the developing situation.
You Can See More: AstraZeneca vaccine side effects: Blood clot risk appears to be 'age related' - Professor
The following article AstraZeneca vaccine side effects: Blood clot risk appears to be 'age related' - Professor is courtesy of Daily Express :: Health Feed
THE ASTRAZENECA vaccine rollout has been dogged by problems in Europe, with many countries sitting on unused supplies over blood clot fears. Despite regulatory bodies concluding there is no causation, rare cases of blood clots do appear to be greater in a younger cohort. Now Professor Neil Ferguson has weighed in on the developing situation.
THE ASTRAZENECA vaccine rollout has been dogged by problems in Europe, with many countries sitting on unused supplies over blood clot fears. Despite regulatory bodies concluding there is no causation, rare cases of blood clots do appear to be greater in a younger cohort. Now Professor Neil Ferguson has weighed in on the developing situation.
0 comments:
Post a Comment
Note: Only a member of this blog may post a comment.